drugset / Trial / NCT03013647

Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization

NCT03013647

NaSingle-groupOpen-labelTreatment

Summary

Twenty patients with multiple actinic keratosis on the face will be enrolled in the study and will be treated with Daylight Photodynamic therapy. Before and after skin biopsies will be performed, for histological and immunohistochemical analysis.

Timeline

Start
2016-09
Primary completion
2017-04
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Subject methyl aminolevulinate Small molecule Topical

Indications